Nkeiru Abovwe, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nkeiru Abovwe’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$1,371
Medicare paid this office $1,371 for 19 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 18 | $1,324 | $51 |
Who their Medicare patients are
19 Original Medicare patients in 2024. Average age 75 · Health risk score 2.98. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Chronic kidney disease 58%.
The office billed $3,200, Medicare allowed $1,721 and paid $1,371; for 27 services of 2 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 19 | 27 | 75 | 2.98 | $3,200 | $1,371 |
| 2023 | 293 | 319 | 77 | 1.58 | $103,379 | $27,818 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 281 | $26,972 | $91 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 13 | $505 | $39 |
Drugs they prescribed that Part D paid
$62,397
Pharmacies billed $62,397 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 630) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
573 generic and 57 brand-name prescriptions · $62,397 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 16 | $20,440 | $1,278 |
| Entresto | 11 | $13,015 | $1,183 |
| Clopidogrel | 87 | $1,481 | $17 |
| Atorvastatin | 98 | $1,222 | $12 |
| Nitroglycerin | 41 | $1,202 | $29 |
See all 12 drugs
| Eliquis | 16 | $20,440 | $1,278 |
| Entresto | 11 | $13,015 | $1,183 |
| Clopidogrel | 87 | $1,481 | $17 |
| Atorvastatin | 98 | $1,222 | $12 |
| Nitroglycerin | 41 | $1,202 | $29 |
| Pantoprazole | 91 | $1,087 | $12 |
| Isosorbide Mononitrate Er | 43 | $569 | $13 |
| Metoprolol | 44 | $472 | $11 |
| Rosuvastatin | 16 | $248 | $15 |
| Carvedilol | 13 | $197 | $15 |
| Metoprolol | 21 | $179 | $9 |
| Amlodipine Besylate | 15 | $168 | $11 |
Year by year
| 2024 | 630 | 186 | 0% (0) | 9% | $62,397 |
| 2023 | 686 | 252 | None | None | $165,249 |
| 2022 | 319 | 29 | None | None | $99,942 |
| 2021 | 330 | 34 | None | 6% | $101,157 |
| 2020 | 314 | 30 | None | None | $143,680 |
| 2019 | 101 | None | None | None | $43,995 |
| 2018 | 87 | 47 | None | None | $4,720 |
| 2017 | 203 | 53 | None | None | $11,981 |
| 2016 | 186 | 25 | 0% (0) | None | $26,709 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 41 | $48,575 | $1,185 |
| Xarelto | 19 | $24,419 | $1,285 |
| Entresto | 11 | $10,639 | $967 |
| Atovaquone | 12 | $9,777 | $815 |
| Valganciclovir | 20 | $4,547 | $227 |
| Metoprolol | 71 | $1,706 | $24 |
| Diltiazem 24hr Er (Cd) | 11 | $1,642 | $149 |
| Atorvastatin | 44 | $823 | $19 |
| Carvedilol | 29 | $531 | $18 |
| Nitroglycerin | 19 | $405 | $21 |
| Isosorbide Mononitrate Er | 13 | $320 | $25 |
| Amlodipine Besylate | 30 | $316 | $11 |
| Pantoprazole | 20 | $282 | $14 |
| Rosuvastatin | 14 | $240 | $17 |
| Clopidogrel | 12 | $230 | $19 |
| Lisinopril | 23 | $223 | $10 |
| Furosemide | 27 | $194 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $161 | $13 |
| Spironolactone | 17 | $152 | $9 |
| Metoprolol | 19 | $126 | $7 |
2022: 6 drugs
| Valganciclovir | 30 | $16,732 | $558 |
| Itraconazole | 12 | $10,803 | $900 |
| Rosuvastatin | 41 | $970 | $24 |
| Nystatin | 12 | $544 | $45 |
| Sulfamethoxazole-Trimethoprim | 40 | $210 | $5 |
| Pantoprazole | 29 | $179 | $6 |
2021: 10 drugs
| Itraconazole | 17 | $16,483 | $970 |
| Valganciclovir | 31 | $16,264 | $525 |
| Atovaquone | 13 | $12,359 | $951 |
| Tacrolimus | 13 | $1,021 | $79 |
| Rosuvastatin | 33 | $877 | $27 |
| Nystatin | 21 | $774 | $37 |
| Prednisone | 16 | $163 | $10 |
| Sulfamethoxazole-Trimethoprim | 25 | $160 | $6 |
| Famotidine | 19 | $119 | $6 |
| Pantoprazole | 21 | $110 | $5 |
2020: 9 drugs
| Posaconazole | 21 | $91,153 | $4,341 |
| Itraconazole | 13 | $12,367 | $951 |
| Valganciclovir | 15 | $8,339 | $556 |
| Nystatin | 25 | $905 | $36 |
| Pantoprazole | 34 | $292 | $9 |
| Sulfamethoxazole-Trimethoprim | 30 | $244 | $8 |
| Famotidine | 24 | $163 | $7 |
| Amiodarone | 13 | $101 | $8 |
| Metoprolol | 13 | $42 | $3 |
2019: 3 drugs
| Itraconazole | 12 | $14,036 | $1,170 |
| Nystatin | 13 | $461 | $35 |
| Sulfamethoxazole-Trimethoprim | 12 | $66 | $6 |
2017: 2 drugs
| Pantoprazole | 15 | $183 | $12 |
| Prednisone | 12 | $84 | $7 |
2016: 3 drugs
| Pantoprazole | 17 | $200 | $12 |
| Prednisone | 15 | $135 | $9 |
| Lisinopril | 12 | $30 | $3 |
Money from drug and device companies
$161 in 2025
| 2025 | 2 | 6 | None | $161 |
| 2023 | 2 | 2 | None | $174 |
| 2022 | 2 | 2 | None | $213 |
| 2021 | 1 | 1 | None | $94 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Rotablator Rotational Atherectomy System Console Kit | $127 | 5 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $33 | 1 payment
|
See all 6 published payments
| Boston Scientific | Meals · 2025-08-21 | Rotablator Rotational Atherectomy System Console Kit | $25 |
| Boston Scientific | Meals · 2025-05-29 | Rotablator Rotational Atherectomy System Console Kit | $25 |
| Boston Scientific | Meals · 2025-05-06 | Opticross | $26 |
| Edwards Lifesciences | Meals · 2025-05-01 | Sapien 3 Ultra Resilia | $33 |
| Boston Scientific | Meals · 2025-04-14 | Farapulse | $36 |
| Boston Scientific | Meals · 2025-03-26 | Avvigo Guidance System | $14 |
See earlier years (2023, 2022, 2021)
2023: $174
| Inari Medical | Ct Thrombectomy System Kit | $151 | 1 payment
|
| Boston Scientific | None | $23 | 1 payment
|
2022: $213
| Amgen | Repatha | $125 | 1 payment
|
| Scynexis | None | $88 | 1 payment
|
2021: $94
| Abbott Laboratories | Heartmate 3 Left Ventricular Assist Device | $94 | 1 payment
|
Professional record
- NPI
- 1467878447
- Licence
- CA 95009634
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-03-13
- NPI last updated
- 2024-11-12
- NPI record certified
- 2024-11-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 365 Hawthorne Ave Ste 201, Oakland, CA, 94609